Department


Pharmacy Practice

Professor
Focus: Endocrinology

Contact Information
(518) 694-7239
michael.kane@acphs.edu


Speaker Request
Michael P. Kane, PHARM.D., FCCP, BCPS, BCACP

EDUCATION

  • Pharm.D., Medical University of South Carolina 
  • Clinical Pharmacy Resident, Adult Internal Medicine, Medical University Hospital Medical University of South Carolina, Charleston, SC
  • Hospital Pharmacy Resident, Greenwich Hospital Association Greenwich, CT 
  • B.S., Albany College of Pharmacy and Health Sciences

COURSES TAUGHT AT ACPHS

  • Integrated Problem Solving Workshop 6 (Facilitator)
  • PTPM Endocrinology
  • APPE - Ambulatory Care Endocrinology/Internal Medicine rotation

RESEARCH INTERESTS

  • Assessing the safety and efficacy of new drugs in the management of diabetes mellitus and osteoporosis.

HONORS AND APPOINTMENTS

  • Elected Fellow of the American College of Clinical Pharmacy, June 2003
  • Recipient of the 2003 Researcher of the Year Award bestowed by the New York State Chapter of the American College of Clinical Pharmacy, May 21, 2004, Syracuse, NY
  • Clinical practice site identified as the “Favorite Rotation” of ACP clerkship students for 2004; presented March 2005.
  • Voted 2005 Most Valuable Player of the Capital District 37 and over Men’s Senior Baseball League
  • Visiting Professor Award: Visiting Expert in Pharmacy, Endocrinology; Health Manpower Development Plan, Singapore Ministry of Health, Feb 16-27, 2009, Singapore
  • Recipient of the 2010 American College of Clinical Pharmacy, Clinical Practice Award; presented October 14, 2010, Austin, TX
  • Appointed to Board of Trustees of Northeast Kidney Foundation – 2015.
  • Biography was accepted into Marquis Who's Who in the World (comprised of the top 3% of the professionals in the world) – 2018.
  • Selected 2019-2020 Albany College of Pharmacy and Health Sciences Preceptor of the Year, October, 2020.
  • Elected to the Capital District Men’s Senior Baseball League Hall of Fame – 2020.

CLINICAL AFFILIATIONS

  • Clinical Pharmacy Specialist – Albany Medical Center Division of Community Endocrinology (formerly The Endocrine Group), Albany, NY
  • Preceptor – Residency in Adult Internal Medicine/Endocrinology
  • Fellow of the American College of Clinical Pharmacy
  • Board Certified in Pharmacotherapy (since 1991)
  • Board Certified in Ambulatory Care Pharmacy (since 2011)

SCHOLARLY ACTIVITY

PUBLICATIONS
  • Arceri V, Kane MP. Hyperthyroidism. In Pharmacotherapy Principles and Practice Study Guide: A Case Based Care Plan Approach, 6th edition (a companion textbook to the 6th edition of Chisholm-Burns et al. Pharmacotherapy Principles and Practice); Sept 2022. 
  • Kane MP, Bakst G. Thyroid Disorders. In DiPiro JT, Yee GC, Posey L, Haines ST, Nolin TD, Ellingrod V. eds. Pharmacotherapy: A Pathophysiologic Approach, 12e New York, NY: McGraw-Hill; 2022; Chapter 96: Thyroid Disorders; 1-50. 
  • Cibotaru D, Celestin MN, Kane MP, Musteata M. Comparison of Liquid-Liquid Extraction, Microextraction, and Ultrafiltration for Measuring Free Concentration of Testosterone and Phenytoin. Bioanalysis. 2022;14(4): 195-204.
  • Quinn HB, Busch RS, Kane MP. The Occurrence and Burden of Hypophosphatasia in an Ambulatory Care Endocrinology Practice. Endocrine Practice, 2021;27:1189-1192. 
  • Cibotaru D, Celestin MN, Kane MP, Musteata M. Method for Simultaneous Determination of Free Concentration, Total Concentration, and Plasma Binding Capacity in Clinical Samples. J Pharm Sci 2021;110:1401-11.doi: 10.1016/j.xphs.2020.12.001.
  • Kane MP, Triplitt C, Solis-Herrera C. Management of type 2 diabetes with oral semaglutide: Practical guidance for pharmacists. Am J Health Syst Pharm . 2021 Mar 18;78(7):556-567. doi: 10.1093/ajhp/zxaa413.
  • Kane MP, Bakst G. Thyroid disorders. In: DiPiro JT, Yee GC, Posey LM, Haines ST, Nolin TD, Ellingrod V, eds. Pharmacotherapy: A Pathophysiologic Approach, 11ed. New York, NY: McGraw-Hill Education, 2019.
  • Kane MP, Triplitt C, Solis-Herrera C. Management of type 2 diabetes with oral semaglutide: Practical guidance for pharmacists. Accepted for publication, American Journal of Health-System Pharmacy.
  • Kuchis MM, Eldeiry A, Busch RS, Racz MJ, Kane MP. Real-World Long-Term Safety and Efficacy of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors. Endocr Pract (Abstract). 2020;26(suppl 2):166-167.
  • Updates in Therapeutics ACCP/ASHP Ambulatory Care Pharmacy Preparatory Review and Recertification Course, 2020 ed. Lenexa, KS: American College of Clinical Pharmacy, 2020:47-108.
  • Kuchis M, Kane MP. iForumRX PodCast and Script - Subclinical Hypothyroidism: Don’t Let the Numbers Fool You: Levothyroxine Isn’t a Cure-all. March 3, 2020 https://iforumrx.org/commentary/don%E2%80%99t-let-numbers-fool-you-levo…
  • McGreevy JL, Kane MP, Busch RS, Bakst G, ElDeiry SS. A pharmacist-run anabolic osteoporosis clinic: An abaloparatide descriptive report. J Am Pharm Assoc. 2019;59(4):593-597. 
  • Kane MP, Bakst G. Thyroid disorders. In: DiPiro JT, Yee GC, Posey LM, Haines ST, Nolin TD, Ellingrod V, eds. Pharmacotherapy: A Pathophysiologic Approach, 11ed. New York, NY: McGraw-Hill Education, 2019.
  • Farina K, Kane MP. Programmed Cell Death-1 Monoclonal Antibody Therapy and Type 1 Diabetes Mellitus: A Review of the Literature. J Pharm Pract. 2019 Jul 3:897190019850929. doi: 10.1177/0897190019850929 
  • Endocrine Disorders. In: Bainbridge JL, Cardone K, Cross LB, et al. Updates in Therapeutics ACCP/ASHP Ambulatory Care Pharmacy Preparatory Review and Recertification Course, 2019 ed. Lenexa, KS: American College of Clinical Pharmacy, 2019:631-93.
SELECTED POSTER/PLATFORM PRESENTATIONS
  • Arceri V, Kane MP, Quinn HB, Telese M, Racz M, Busch RS. Abaloparatide implementation and follow-up: Real-world results of a pharmacist-run anabolic osteoporosis clinic. Poster presented at the 2022 Endocrine Society Annual Meeting, Atlanta, GA, June 11, 2022. 
  • Updates in Diabetes Management: The Elderly. Presented at the New York American Society of Consultant Pharmacists Mid-State Chapter Meeting, Syracuse, NY, June 1, 2022. 
  • The Evolving Treatment Paradigm for Osteoporosis: The Integral Role of the Pharmacist in Optimizing Care. Pharmacy Times CE, Cranbury, NJ, April 27, 2022. 
  • Quinn HB, Busch RS, Kane MP. Abstract Number: 8734 The Endocrine Society Annual Meeting. Abstract Title: The Prevalence and Burden of Hypophosphatasia in an Ambulatory Endocrinology Practice. Poster session: P08. Parathyroid and Rare Bone Disorders. Took place online, ENDO 2021, March 20-23, 2021. 
  • PSSNY/CPESN Diabetes Self Care Management (DSMES) Boot Camp. Update on Diabetes: Medications, Clinical Guidelines, and Treatment Recommendations. Presented Nov 8, 2020, virtual presentation.
  • Kuchis MM, Eldeiry A, Busch RS, Racz M, Kane MP. Real-world long-term safet y and efficacy of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors. EMBRAACE 2020: The AACE 29th Annual Scientific & Clinical Congress; Washington, DC May 10, 2020. (On-line presentation due to COVID-19 pandemic).
  • ACCP/ASHP 2020 Ambulatory Care Pharmacy Preparatory Review and Recertification Course; Endocrine Disorders. Presented March 5, 2020, Henderson, NV.
  • Current Issues in Hypothyroidism. The Nurse Practitioner Association New York State 35th Annual Conference. Presented October 19, 2019, Verona, NY.
  • ACCP/ASHP 2019 Ambulatory Care Pharmacy Preparatory Review and Recertification Course; Endocrine Disorders. Presented May 3, 2019, Minneapolis, MN.
  • McGreevy JL, Cherian S, Kane MP, Busch RS, Racz M. A real-world GLP-1 receptor agonist switch study. Presented at the ACCP/ASHP Updates in Therapeutics 2019 meeting, St. Louis College of Pharmacy, St. Louis, Missouri, April 28, 2019.
RESEARCH GRANTS

Abaloparatide implementation and follow-up: Real-world results of a pharmacist-run anabolic osteoporosis clinic. Kane MP, Arceri V, Quinn H, Busch RS. Radius Pharmaceuticals, $42,640; Dec 2021.

The Prevalence and Burden of Hypophosphatasia in an Ambulatory Care Endocrinology Practice. Kane MP, Quinn H, Busch RS. Awarded $42,640; Alexion Pharmaceuticals; July 2020.

Simultaneous Determination of Free, Total, and Normalized Concentrations of Bioactive Compounds. Musteata FM, Kane MP. National Institutes of Health. Grant Number: 1R15GM126510-01  FAIN: R15GM126510. Awarded $480,000. 09/01/2018 – 08/31/2021.